Our September newsletter explores trends that were identified in this years ESI Outcomes Conference. From drugs coming off patent to a shift to biological drugs, there is no doubt that these changes will have an impact on benefit programs. Benefit administrators should pay close attention.
Posted in Newsletter |
You can follow any responses to this entry through the RSS 2.0 feed.
Trackback from your own site.